In the second episode of their EXTRACTED podcast, presented in partnership with Leafly, Valens GroWorks Corp (CSE:VGW) hosted US-based cannabis educator Emma Chasen.

Chasen is the co-founder and CEO of Eminent Consulting Firm, based in Portland, Oregon. In the interview, she discussed her path to the cannabis industry, which was prompted by her interest in plant medicine. As she began to develop her knowledge on the plant, she discovered a significant gap in the industry in terms of standardized knowledge. This gap is what she is trying to mitigate with the work that she does for the industry.


During the podcast, she addressed a number of topics including how legalization is unfolding in Canada, where bud tenders are still not allowed to discuss the properties of cannabis strains with consumers. Chasen discussed her concern regarding the limited view consumers get into cannabis, a plant which holds many more compounds than just CBD and THC, including many that have yet to be discovered. She addressed the importance of terpenes in cannabis and how they influence the physiological properties of the plant.

Chasen also discussed the difference between flower and oil products—which are the only products available on the Canadian market so far—entourage effect vs. ensemble effect, the concerns related to pesticide use, labeling practices and more.

To listen to the entire podcast episode, click here.

Click here to connect with Valens GroWorks Corp (CSE:VGW) for an Investor Presentation.

Source: www.valensgroworks.com

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less